Effects of GTS-21 on Smoking Behavior and Neurocognitive Functions

Summary

Attempts to quit cigarette smoking are often accompanied by negative mood and problems in attention and memory. These effects, in turn, may contribute to smoking relapse. This exploratory/developmental project examines the effects of a novel medication, GTS-21, on individuals interested in smoking cessation. It is hypothesized that GTS-21 will reduce negative affect, improve cognition and/or reduce smoking relapse in healthy adult men and women who are chronic cigarette smokers.

Timeline

Start

2018-09-29

Primary completion

2018-12-29

Completion

2020-12-29

Drugs

Indications